IDEX Biometrics ASA: Approved prospectus - 21 May 2025

21 May 2025 08:45 CEST

Reference is made to the stock exchange announcements issued by IDEX Biometrics
ASA (the "Company") on 11 March and 11 April 2025 regarding the successful loan
financing of NOK 30 million and the subsequent conversion of such debt to shares
in the Company at a subscription price of NOK 0.01 per share, resulting in the
issuance of 3,000,000,000 new shares ("Debt Conversion" and "Debt Conversion
Shares"), the subsequent offering of up to 600,000,000 new shares at a
subscription price equal to the subscription price in the Debt Conversion
("Subsequent Offering" and the "Offer Shares"), and the amendment of a certain
senior convertible bond (the "Convertible Bond") issued by an affiliate of
Heights Capital Management ("Heights") to the Company, whereby, among other
things, the principal amount of the Convertible Bond was reduced to an aggregate
principal amount of NOK 49,980,000.

The listing of the Debt Conversion Shares, the Subsequent Offering and the
listing of the Offer Shares remain subject to approval of a prospectus
("Prospectus") by the Financial Supervisory Authority of Norway ("FSA"), and the
subsequent publication of such Prospectus by the Company. Further, the future
listing of shares that may be issued by the Company upon conversion of the
Convertible Bond (the conversion price currently being NOK 0.065, but which
conversion price is subject to customary adjustment provisions) also remains
subject to approval and publication of a Prospectus.

The FSA has today approved the Prospectus. As a result of the above, the
subscription period for the Subsequent Offering starts on 22 May 2025 and
expires on 5 June 2025 at 16:30 CET. For further information on the Subsequent
Offering, please refer to the Prospectus.

Further, by reason of the approval and publication of the Prospectus, the Debt
Conversion Shares will be transferred to the Company's ordinary ISIN and be
admitted to trading on Oslo Børs.

The Prospectus is enclosed with this announcement. It will also be available in
electronic format at www.idexbiometrics.com/investors/share-
information/prospectuses .

Printed copies of the Prospectus may be obtained free of charge at the office of
IDEX Biometrics ASA, Dronning Eufemias gate 16, NO-0191 Oslo, Norway, telephone
+47 6783 9119 or by e-mail: companysecretary@idexbiometrics.com.

Arctic Securities AS acts as financial advisor and bookrunner in connection with
the Subsequent Offering (the "Manager"). Ræder Bing advokatfirma AS acts as the
Company's legal advisor.

For further information, please contact:

Kristian Flaten, CFO, Tel: +47 95092322

E-mail: ir@idexbiometrics.com (mailto:ir@idexbiometrics.com)

About IDEX Biometrics:

IDEX Biometrics ASA (OSE: IDEX) is a global technology leader in fingerprint
biometrics, offering authentication solutions across payments, access control,
and digital identity. Our solutions bring convenience, security, peace of mind
and seamless user experiences to the world. Built on patented and proprietary
sensor technologies, integrated circuit designs, and software, our biometric
solutions target card-based applications for payments and digital
authentication. As an industry-enabler we partner with leading card
manufacturers and technology companies to bring our solutions to market. For
more information, visit www.idexbiometrics.com (http://www.idexbiometrics.com)

About this notice:

This notice was issued by Kristian Flaten, CFO, on 21 May 2025 at 08:45 CET on
behalf of IDEX Biometrics ASA. This information is subject to the disclosure
requirements pursuant to the Norwegian Securities Trading Act section 5-12.

More information:
Access the news on Oslo Bors NewsWeb site

647004_2025-05-21 Prospectus incl subscription form- IDEX Biometrics ASA.pdf